These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29471464)

  • 61. Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011.
    Ann J; Papenburg J; Bouhy X; Rhéaume C; Hamelin MÈ; Boivin G
    J Clin Virol; 2012 Jan; 53(1):88-92. PubMed ID: 22036039
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Retrospective Assessment of the Antigenic Similarity of Egg-Propagated and Cell Culture-Propagated Reference Influenza Viruses as Compared with Circulating Viruses across Influenza Seasons 2002-2003 to 2017-2018.
    Rajaram S; Suphaphiphat P; van Boxmeer J; Haag M; Leav B; Iheanacho I; Kistler K; Ortiz de Lejarazu R
    Int J Environ Res Public Health; 2020 Jul; 17(15):. PubMed ID: 32731417
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.
    Herrera GA; Iwane MK; Cortese M; Brown C; Gershman K; Shupe A; Averhoff F; Chaves SS; Gargiullo P; Bridges CB
    Vaccine; 2007 Jan; 25(1):154-60. PubMed ID: 17064823
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An epidemic surge of influenza A(H3N2) virus at the end of the 2016-2017 season in Taiwan with an increased viral genetic heterogeneity.
    Yang JR; Hsu SZ; Kuo CY; Huang HY; Huang TY; Wang HC; Liu MT
    J Clin Virol; 2018; 99-100():15-21. PubMed ID: 29278832
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genetic drift of influenza A(H3N2) viruses during two consecutive seasons in 2011-2013 in Corsica, France.
    Fantoni A; Arena C; Corrias L; Salez N; de Lamballerie XN; Amoros JP; Blanchon T; Varesi L; Falchi A
    J Med Virol; 2014 Apr; 86(4):585-91. PubMed ID: 24105757
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection.
    Pebody R; Andrews N; McMenamin J; Durnall H; Ellis J; Thompson CI; Robertson C; Cottrell S; Smyth B; Zambon M; Moore C; Fleming DM; Watson JM
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399424
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons.
    Hiroi S; Morikawa S; Nakata K; Maeda A; Kanno T; Irie S; Ohfuji S; Hirota Y; Kase T
    Hum Vaccin Immunother; 2015; 11(2):386-90. PubMed ID: 25692378
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Effectiveness of Influenza Vaccine in Adults Using A Test-negative, Case-control Design ―2013/2014 and 2014/2015 Seasons―].
    Seki Y; Oonishi H; Onose A; Sugaya N
    Kansenshogaku Zasshi; 2016 Jul; 90(4):486-92. PubMed ID: 30212035
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs.
    Harding AT; Heaton BE; Dumm RE; Heaton NS
    mBio; 2017 Jun; 8(3):. PubMed ID: 28588131
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany.
    Remschmidt C; Rieck T; Bödeker B; Wichmann O
    BMC Infect Dis; 2015 Mar; 15():137. PubMed ID: 25887460
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China.
    Zhang Y; Wu P; Feng L; Yang P; Pan Y; Feng S; Qin Y; Zheng J; Puig-Barberà J; Muscatello D; MacIntyre R; Cowling BJ; Yu H; Wang Q
    Vaccine; 2017 May; 35(23):3129-3134. PubMed ID: 28456530
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
    Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A;
    Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713
    [TBL] [Abstract][Full Text] [Related]  

  • 74. H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.
    Allen JD; Ross TM
    Hum Vaccin Immunother; 2018; 14(8):1840-1847. PubMed ID: 29641358
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.
    Zhong W; Gross FL; Holiday C; Jefferson SN; Bai Y; Liu F; Katz JM; Levine MZ
    Viral Immunol; 2016 May; 29(4):259-62. PubMed ID: 26950058
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
    Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of human H3N2 influenza virus reassortment on influenza incidence and severity during the 2017-18 influenza season in the USA: a retrospective observational genomic analysis.
    Liu H; Shaw-Saliba K; Westerbeck J; Jacobs D; Fenstermacher K; Chao CY; Gong YN; Powell H; Ma Z; Mehoke T; Ernlund AW; Dziedzic A; Vyas S; Evans J; Sauer LM; Wu CC; Chen SH; Rothman RE; Thielen P; Chen KF; Pekosz A
    Lancet Microbe; 2024 Aug; 5(8):100852. PubMed ID: 38734029
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Real-time real-world analysis of seasonal influenza vaccine effectiveness: method development and assessment of a population-based cohort in Stockholm County, Sweden, seasons 2011/12 to 2014/15.
    Leval A; Hergens MP; Persson K; Örtqvist Å
    Euro Surveill; 2016 Oct; 21(43):. PubMed ID: 27813473
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.
    Flannery B; Chung JR; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Foust A; Sessions W; Berman L; Barnes JR; Spencer S; Fry AM
    MMWR Morb Mortal Wkly Rep; 2018 Feb; 67(6):180-185. PubMed ID: 29447141
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
    Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
    J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.